• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗药物滥用者的抑郁症。

Treating depression in substance abusers.

作者信息

Nunes Edward V, Levin Frances R

机构信息

New York State Psychiatric Institute, 1051 Riverside Drive (Unit 51), New York, NY 10032, USA.

出版信息

Curr Psychiatry Rep. 2006 Oct;8(5):363-70. doi: 10.1007/s11920-006-0037-8.

DOI:10.1007/s11920-006-0037-8
PMID:16968616
Abstract

The literature on the diagnosis and treatment of depression is reviewed to arrive at recommendations for clinical practice, future research, and models of service delivery. The DSM-IV criteria are found to provide a sound basis for diagnosis, and a review of placebo-controlled trials of antidepressant medications among substance-dependent patients suggests medication is effective in the setting of careful diagnosis, preferably during a currently observed abstinent period. Clinical recommendations offered for the approach to patients with co-occurring depression and substance dependence include the following: 1) Initiate treatment for substance dependence and encourage abstinence; 2) Conduct a careful psychiatric history and apply DSM-IV criteria for primary or substance-induced depression; 3) If depression meets diagnostic criteria and persists despite treatment of substance use disorder, treat the depression. Future research should include trials of psychotherapeutic or behavioral treatments, studies of treatment algorithms and of integrated systems of care, and studies of methods for disseminating diagnostic and treatment methods in an effort to diminish traditional boundaries between the skill sets of mental health and substance abuse clinicians.

摘要

对抑郁症诊断与治疗的文献进行综述,以得出关于临床实践、未来研究及服务提供模式的建议。发现《精神疾病诊断与统计手册》第四版(DSM-IV)标准为诊断提供了可靠依据,对物质依赖患者中抗抑郁药物的安慰剂对照试验的综述表明,在仔细诊断的情况下,药物治疗是有效的,最好是在当前观察到的戒断期进行。针对同时患有抑郁症和物质依赖的患者所提供的临床建议如下:1)开始对物质依赖进行治疗并鼓励戒断;2)进行详细的精神病史询问,并应用DSM-IV标准诊断原发性或物质所致抑郁症;3)如果抑郁症符合诊断标准且尽管对物质使用障碍进行了治疗仍持续存在,则对抑郁症进行治疗。未来的研究应包括心理治疗或行为治疗的试验、治疗算法及综合护理系统的研究,以及传播诊断和治疗方法的研究,以努力消除心理健康和药物滥用临床医生技能集之间的传统界限。

相似文献

1
Treating depression in substance abusers.治疗药物滥用者的抑郁症。
Curr Psychiatry Rep. 2006 Oct;8(5):363-70. doi: 10.1007/s11920-006-0037-8.
2
[Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription].[使用患者健康问卷评估法国全科医疗中精神障碍的患病率:与全科医生病例识别及精神药物处方的比较]
Encephale. 2009 Dec;35(6):560-9. doi: 10.1016/j.encep.2008.06.018.
3
Independent versus substance-induced major depressive disorder in substance-dependent patients: observational study of course during follow-up.物质依赖患者中独立型与物质所致重度抑郁症:随访期间病程的观察性研究
J Clin Psychiatry. 2006 Oct;67(10):1561-7. doi: 10.4088/jcp.v67n1010.
4
Comorbidity of substance use with depression and other mental disorders: from Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) to DSM-V.物质使用与抑郁症及其他精神障碍的共病:从《精神疾病诊断与统计手册》第四版(DSM-IV)到第五版(DSM-V)
Addiction. 2006 Sep;101 Suppl 1:89-96. doi: 10.1111/j.1360-0443.2006.01585.x.
5
Prevalence of substance use and psychiatric disorders in a highly select chronic pain population.高度选择的慢性疼痛人群中物质使用和精神障碍的患病率。
J Addict Med. 2013 Jan-Feb;7(1):17-24. doi: 10.1097/ADM.0b013e3182738655.
6
Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.给编辑的信:《ICD-11 与 DSM-5 心境障碍分类的趋同与分歧》
Turk Psikiyatri Derg. 2021;32(4):293-295. doi: 10.5080/u26899.
7
Comorbidity of major depression with substance use disorders.重度抑郁症与物质使用障碍的共病情况。
Can J Psychiatry. 2005 Sep;50(10):660-6. doi: 10.1177/070674370505001013.
8
Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis.酒精或其他药物依赖患者抑郁症的治疗:一项荟萃分析。
JAMA. 2004 Apr 21;291(15):1887-96. doi: 10.1001/jama.291.15.1887.
9
Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV.诊断药物滥用者的共病精神障碍:《物质与精神障碍精神科研究访谈》和《精神疾病诊断与统计手册》第四版结构化临床访谈西班牙语版本的效度
Am J Psychiatry. 2004 Jul;161(7):1231-7. doi: 10.1176/appi.ajp.161.7.1231.
10
ECNP consensus meeting. Bipolar depression. Nice, March 2007.欧洲神经精神药理学会共识会议。双相抑郁症。英国尼斯,2007年3月。
Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23.

引用本文的文献

1
Modulation of 5-HT release by dynorphin mediates social deficits during opioid withdrawal.内啡肽调制 5-HT 释放介导阿片类戒断期间的社交缺陷。
Neuron. 2022 Dec 21;110(24):4125-4143.e6. doi: 10.1016/j.neuron.2022.09.024. Epub 2022 Oct 5.
2
Substance use disorders and risk for treatment resistant depression: a population-based, nested case-control study.物质使用障碍与治疗抵抗性抑郁症风险:基于人群的巢式病例对照研究。
Addiction. 2020 Apr;115(4):768-777. doi: 10.1111/add.14866. Epub 2019 Dec 16.
3
Treatment-resistant depression as risk factor for substance use disorders-a nation-wide register-based cohort study.

本文引用的文献

1
Comorbidity of substance use with depression and other mental disorders: from Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) to DSM-V.物质使用与抑郁症及其他精神障碍的共病:从《精神疾病诊断与统计手册》第四版(DSM-IV)到第五版(DSM-V)
Addiction. 2006 Sep;101 Suppl 1:89-96. doi: 10.1111/j.1360-0443.2006.01585.x.
2
Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV.使用《精神疾病诊断与统计手册第四版》物质与精神障碍的精神病学研究访谈对物质使用者共病精神障碍的诊断。
Am J Psychiatry. 2006 Apr;163(4):689-96. doi: 10.1176/ajp.2006.163.4.689.
3
治疗抵抗性抑郁症是物质使用障碍的一个风险因素:一项全国范围内基于登记的队列研究。
Addiction. 2019 Jul;114(7):1274-1282. doi: 10.1111/add.14596. Epub 2019 Apr 15.
4
Demographic and clinical characteristics of current comorbid psychiatric disorders in a randomized clinical trial for adults with stimulant use disorders.针对患有兴奋剂使用障碍的成年人的一项随机临床试验中当前共病精神障碍的人口统计学和临床特征。
Psychiatry Res. 2016 Dec 30;246:136-141. doi: 10.1016/j.psychres.2016.09.007. Epub 2016 Sep 15.
5
Gender-specific effects of comorbid depression and anxiety on the propensity to drink in negative emotional states.共病抑郁和焦虑对负面情绪状态下饮酒倾向的性别特异性影响。
Addiction. 2016 Aug;111(8):1366-75. doi: 10.1111/add.13386. Epub 2016 May 5.
6
Kappa opioid receptor antagonism and chronic antidepressant treatment have beneficial activities on social interactions and grooming deficits during heroin abstinence.κ阿片受体拮抗作用和慢性抗抑郁治疗对海洛因戒断期间的社交互动和梳理行为缺陷具有有益作用。
Addict Biol. 2017 Jul;22(4):1010-1021. doi: 10.1111/adb.12392. Epub 2016 Mar 22.
7
Pathways to Vulnerability for Alcohol Problem Severity in a Treatment-Seeking Sample.寻求治疗样本中酒精问题严重程度的易感性途径。
Addict Disord Their Treat. 2015 Jun;14(2):82-94. doi: 10.1097/ADT.0000000000000045.
8
Depressive Symptoms and Associated Clinical Characteristics in Outpatients Seeking Community-Based Treatment for Alcohol and Drug Problems.寻求社区酒精和药物问题治疗的门诊患者的抑郁症状及相关临床特征
Subst Abus. 2015;36(3):297-303. doi: 10.1080/08897077.2014.937845. Epub 2014 Aug 1.
9
Pretreatment clinical and risk correlates of substance use disorder patients with primary depression.初诊抑郁症伴物质使用障碍患者的治疗前临床和风险相关性。
J Stud Alcohol Drugs. 2011 Jan;72(1):151-7. doi: 10.15288/jsad.2011.72.151.
10
Sickness absence as a prognostic marker for common chronic conditions: analysis of mortality in the GAZEL study.疾病缺勤作为常见慢性病的预后标志物:GAZEL研究中的死亡率分析。
Occup Environ Med. 2008 Dec;65(12):820-6. doi: 10.1136/oem.2007.038398. Epub 2008 Jul 8.
Sertraline treatment of co-occurring alcohol dependence and major depression.
舍曲林治疗同时存在的酒精依赖和重度抑郁症。
J Clin Psychopharmacol. 2006 Feb;26(1):13-20. doi: 10.1097/01.jcp.0000194620.61868.35.
4
Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress.共病的精神障碍和物质使用障碍:慢性应激的神经生物学效应
Am J Psychiatry. 2005 Aug;162(8):1483-93. doi: 10.1176/appi.ajp.162.8.1483.
5
Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.去甲丙咪嗪治疗伴有抑郁症的可卡因依赖患者:一项安慰剂对照试验。
Drug Alcohol Depend. 2005 Nov 1;80(2):209-21. doi: 10.1016/j.drugalcdep.2005.03.026.
6
Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis.抗抑郁药在伴有或不伴有共病性抑郁的物质使用障碍中的疗效:一项系统评价与荟萃分析。
Drug Alcohol Depend. 2005 Apr 4;78(1):1-22. doi: 10.1016/j.drugalcdep.2004.09.004. Epub 2004 Nov 11.
7
Treatment of depression in patients with opiate dependence.阿片类药物依赖患者的抑郁症治疗。
Biol Psychiatry. 2004 Nov 15;56(10):793-802. doi: 10.1016/j.biopsych.2004.06.037.
8
Discriminating between substance-induced and independent depressive episodes in alcohol dependent patients.区分酒精依赖患者中物质所致抑郁发作和独立抑郁发作。
J Stud Alcohol. 2004 Sep;65(5):672-6. doi: 10.15288/jsa.2004.65.672.
9
Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.物质使用障碍与独立的心境和焦虑障碍的患病率及共病情况:来自国家酒精及相关状况流行病学调查的结果
Arch Gen Psychiatry. 2004 Aug;61(8):807-16. doi: 10.1001/archpsyc.61.8.807.
10
Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis.酒精或其他药物依赖患者抑郁症的治疗:一项荟萃分析。
JAMA. 2004 Apr 21;291(15):1887-96. doi: 10.1001/jama.291.15.1887.